Skip to main content
Log in

Disturbances of diurnal phase markers, behavior, and clock genes in a rat model of depression; modulatory effects of agomelatine treatment

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Major depressive disorder (MDD) is a growing problem worldwide. Though, the etiology remains unresolved, circadian rhythm disturbances are frequently observed in MDD and thus is speculated to play a key role herein. The present study focuses on circadian rhythm disturbances in the chronic mild stress (CMS) animal model of depression and examined whether the atypical antidepressant, agomelatine, which is mediating its action via melatonergic and serotonergic receptors, is capable of resynchronizing the perturbed rhythm. Melatonin is often used as a marker of the circadian phase, but the functional and behavioral output is dictated on a cellular level by the molecular clock, driven by the clock genes. We applied in situ hybridization histochemistry to measure the expression levels of the core clock genes, period (Per) 1 and 2 and bone and muscle ARNT-like protein 1 (Bmal1), in multiple brain regions believed to be implicated in depression. Agomelatine showed an antidepressant-like effect in the sucrose consumption test and an anxiolytic-like profile in the elevated zero maze. We found that CMS increased nighttime melatonin release in rats and that agomelatine attenuated this effect. Stress was shown to have a time and region-specific effect on clock gene expression in the brain. Treatment with agomelatine failed to normalize clock gene expression, and the observed modifying effect on gene expression did not associate with the antidepressant-like effect. This suggests that the antidepressant actions of agomelatine are mainly independent of circadian rhythm synchronization and, in this regard, not superior to traditional antidepressants tested in our model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11

Similar content being viewed by others

Abbreviations

Anh-Veh:

anhedonic vehicle group

Ago-R:

agomelatine responder group

Ago-NR:

agomelatine non-responder group

Bmal1/ARNTL:

aryl hydrocarbon receptor nuclear translocator-like

CMS:

chronic mild stress

Con-Veh:

control vehicle

CA1-3:

cornus ammonis 1-3

DG:

dentate gyrus

OF:

open field

EZM:

elevated zero maze

HP:

Hippocampus

LHb:

lateral habenula

LD:

12:12-h light/dark cycle

MDD:

major depressive disorder

NAc:

nucleus accumbens

SI:

sucrose index

SCN:

suprachiasmatic nucleus

Per1-2:

period genes 1-2

Pi:

pineal gland

PFC:

prefrontal cortex

RM:

repeated measures

SCT:

sucrose consumption test

SNc:

substantia nigra (part compacta)

SI:

sucrose index

ZT:

zeitgeber time

References

Download references

Acknowledgements

We thank Jan Fahrenkrug and Jens Hannibal from Department of Clinical Medicine, Bispebjerg-Frederiksberg Hospital, Copenhagen, for their valuable help with in situ hybridization histochemistry.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to O. Wiborg.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Højgaard, K., Christiansen, S.L., Bouzinova, E.V. et al. Disturbances of diurnal phase markers, behavior, and clock genes in a rat model of depression; modulatory effects of agomelatine treatment. Psychopharmacology 235, 627–640 (2018). https://doi.org/10.1007/s00213-017-4781-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-017-4781-8

Keywords

Navigation